| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| ImmunityBio, Inc. | Director | Stock Option (right to buy) | 162,786 | 18 Jun 2025 | Direct | ||
| NantHealth, Inc. | Director | Stock Option (right to buy) | 100,000 | 09 Jun 2022 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| IBRX | ImmunityBio, Inc. | 18 Jun 2025 | 1 | $0 | 4 | Director | 20 Jun 2025, 18:34 |
| IBRX | ImmunityBio, Inc. | 11 Jun 2024 | 1 | $0 | 4 | Director | 13 Jun 2024, 18:49 |
| IBRX | ImmunityBio, Inc. | 13 Jun 2023 | 1 | $0 | 4 | Director | 15 Jun 2023, 18:24 |
| IBRX | ImmunityBio, Inc. | 05 Jun 2023 | 3 | +$198,023 | 4 | Director | 05 Jun 2023, 21:52 |
| IBRX | ImmunityBio, Inc. | 14 Jun 2022 | 1 | $0 | 4 | Director | 15 Jun 2022, 21:16 |
| /report/000089924322021909-blaszyk-michael-d-2022-06-09 | NantHealth, Inc. | 09 Jun 2022 | 1 | $0 | 4 | Director | 10 Jun 2022, 16:29 |
| /report/000089924321029926-blaszyk-michael-d-2021-06-16 | NantHealth, Inc. | 16 Jun 2021 | 1 | $0 | 4 | Director | 26 Jul 2021, 18:04 |
| IBRX | ImmunityBio, Inc. | 10 Jun 2021 | 1 | $0 | 4 | Director | 14 Jun 2021, 18:31 |